טוען...
Extended Adjuvant Aromatase Inhibitor Therapy in Post-Menopausal Women
PURPOSE OF THE REVIEW: To understand the evidence for extending adjuvant aromatase inhibitor (AI) therapy from 5 to 10 years in post-menopausal women with hormone receptor positive (HR+) breast cancer. RECENT FINDINGS: Multiple large trials have investigated this question. The two trials most repres...
שמור ב:
| הוצא לאור ב: | Curr Breast Cancer Rep |
|---|---|
| Main Authors: | , |
| פורמט: | Artigo |
| שפה: | Inglês |
| יצא לאור: |
2017
|
| נושאים: | |
| גישה מקוונת: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5791913/ https://ncbi.nlm.nih.gov/pubmed/29399271 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s12609-017-0260-9 |
| תגים: |
הוספת תג
אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!
|